Mana.bio

Tel Aviv, Israel · Founded 2021 · Privately Held (backing)

Operator of an artificial intelligence-based drug delivery company intended to facilitate lipid nanoparticle development for oligonucleotide therapies. Mana.bio is based in Tel Aviv, Israel and was founded in 2021. Its last reported valuation was $30.8 million in Oct 2023. It has raised $19.5 million.

Last reported valuation
$30.8M
Oct 2026
Priced at
—
Total raised
$19.5M
Last round
—

Who backs Mana.bio?

7 investors
InvestorType
Andreessen HorowitzVenture capital
GaingelsVenture capital
NFXVenture capital
Base4 CapitalHedge fund
LionBird—
Old Silver VC—
Technion Israel Institute of Technology—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Mana.bio investors

7 investors are on record for Mana.bio, including Andreessen Horowitz, Gaingels, NFX and Base4 Capital.

Free account
More of Mana.bio with a free account
  • ·Watch Mana.bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like Mana.bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View